Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317702906> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W2317702906 abstract "Objective: The purpose of the present study was to assess the influence ofresveratrol onP-glycoprotein mediated drug disposition in humans using fexofenadine as a P-glycoprotein substrate. Methods: A non-blinded, an open label crossover study was conducted in twelve healthy male volunteers aged between 26 and 31 years. A single dose of fexofenadine hydrochloride 120 mg was given to volunteers during control phase and treatment phases. A single dose of resveratrol 500 mg was given to volunteers once daily for period of 10 days. The blood samples were collected at predetermined time intervals during control and treatment phases. The plasma samples containing fexofenadine hydrochloridewere analyzed by LC-MS/MS. The pharmacokinetic parameters were computed by non-compartmental method and the mean pharmacokinetic parameter differences during control and treatment phases were assessed. Results: Treatment with resveratrol significantly increased thearea under the plasma concentration-time curve (AUC) and maximum plasma concentration (Cmax) offexofenadine to 76.7%(2520.92.48 versus 4454.48 ng.h/mL) and 65.2% (415.08 versus 685.58 ng/mL)respectively when compared to control phase. On other hand, apparentoral clearance (CL/F) and apparent volume of distribution (Vd/F) of fexofenadine were significantly decreased by 42.6% (49.46 versus 28.37 L/h) and 42.1 % (591.73 versus 342.62 L) respectively. However, there was no significant change was observed in T1/2, Kel and Tmaxof fexofenadine upon treatment with resveratrol when compared to control phase. Conclusion: The results of the present study showed that multiple doses of resveratrolenhanced the bioavailability of fexofenadine probably by the inhibition of P-glycoprotein mediated drug efflux in humans." @default.
- W2317702906 created "2016-06-24" @default.
- W2317702906 creator A5018539610 @default.
- W2317702906 date "2014-01-01" @default.
- W2317702906 modified "2023-10-16" @default.
- W2317702906 title "Resveratrol Enhances the Bioavailability of Fexofenadine in Healthy Human Male Volunteers: Involvement of P-Glycoprotein Inhibition" @default.
- W2317702906 doi "https://doi.org/10.4172/jbb.10000198" @default.
- W2317702906 hasPublicationYear "2014" @default.
- W2317702906 type Work @default.
- W2317702906 sameAs 2317702906 @default.
- W2317702906 citedByCount "10" @default.
- W2317702906 countsByYear W23177029062015 @default.
- W2317702906 countsByYear W23177029062016 @default.
- W2317702906 countsByYear W23177029062017 @default.
- W2317702906 countsByYear W23177029062019 @default.
- W2317702906 countsByYear W23177029062020 @default.
- W2317702906 countsByYear W23177029062023 @default.
- W2317702906 crossrefType "journal-article" @default.
- W2317702906 hasAuthorship W2317702906A5018539610 @default.
- W2317702906 hasBestOaLocation W23177029061 @default.
- W2317702906 hasConcept C133936738 @default.
- W2317702906 hasConcept C181389837 @default.
- W2317702906 hasConcept C185592680 @default.
- W2317702906 hasConcept C2776711289 @default.
- W2317702906 hasConcept C2776816829 @default.
- W2317702906 hasConcept C2778707650 @default.
- W2317702906 hasConcept C501593827 @default.
- W2317702906 hasConcept C55493867 @default.
- W2317702906 hasConcept C71924100 @default.
- W2317702906 hasConcept C98274493 @default.
- W2317702906 hasConceptScore W2317702906C133936738 @default.
- W2317702906 hasConceptScore W2317702906C181389837 @default.
- W2317702906 hasConceptScore W2317702906C185592680 @default.
- W2317702906 hasConceptScore W2317702906C2776711289 @default.
- W2317702906 hasConceptScore W2317702906C2776816829 @default.
- W2317702906 hasConceptScore W2317702906C2778707650 @default.
- W2317702906 hasConceptScore W2317702906C501593827 @default.
- W2317702906 hasConceptScore W2317702906C55493867 @default.
- W2317702906 hasConceptScore W2317702906C71924100 @default.
- W2317702906 hasConceptScore W2317702906C98274493 @default.
- W2317702906 hasIssue "05" @default.
- W2317702906 hasLocation W23177029061 @default.
- W2317702906 hasOpenAccess W2317702906 @default.
- W2317702906 hasPrimaryLocation W23177029061 @default.
- W2317702906 hasRelatedWork W176809139 @default.
- W2317702906 hasRelatedWork W1965959092 @default.
- W2317702906 hasRelatedWork W2050301997 @default.
- W2317702906 hasRelatedWork W2083913321 @default.
- W2317702906 hasRelatedWork W2139434527 @default.
- W2317702906 hasRelatedWork W2158291672 @default.
- W2317702906 hasRelatedWork W2317702906 @default.
- W2317702906 hasRelatedWork W2319498377 @default.
- W2317702906 hasRelatedWork W3049607835 @default.
- W2317702906 hasRelatedWork W3178612228 @default.
- W2317702906 hasVolume "06" @default.
- W2317702906 isParatext "false" @default.
- W2317702906 isRetracted "false" @default.
- W2317702906 magId "2317702906" @default.
- W2317702906 workType "article" @default.